Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Here, we study the intricate relationship between gut microbiota and host cometabolic phenotypes associated with dietary-induced impaired glucose homeostasis and nonalcoholic fatty liver disease (NAFLD) in a mouse strain (129S6) known to be susceptible to these disease traits, using plasma and urine metabotyping, achieved by (1)H NMR spectroscopy. Multivariate statistical modeling of the spectra shows that the genetic predisposition of the 129S6 mouse to impaired glucose homeostasis and NAFLD is associated with disruptions of choline metabolism, i.e., low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines (dimethylamine, trimethylamine, and trimethylamine-N-oxide), coprocessed by symbiotic gut microbiota and mammalian enzyme systems. Conversion of choline into methylamines by microbiota in strain 129S6 on a high-fat diet reduces the bioavailability of choline and mimics the effect of choline-deficient diets, causing NAFLD. These data also indicate that gut microbiota may play an active role in the development of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal role for the involvement of gut microbes is in part based on the fulfillment of one of Koch’s postulates - namely, the transmission of a disease related phenotype with transplantation of gut microbial organisms to a new host (Cho and Blaser, 2012; Cox et al., 2014; Dumas et al., 2006; Gregory et al., 2015; Koch, 1880; Sandhu and Chase, 1986).”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Dumas et al., 2006
In the citing paper
“Interestingly, dysbiotic microbiota from mice fed a high-fat diet metabolize and convert dietary choline into methylamines, resulting in low circulating levels of plasma phosphatidylcholine60.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [60]
In the citing paper
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [39]
In the citing paper
“It has been demonstrated that the gut microbiota can play a role in the development of metabolic abnormalities such as insulin resistance and nonalcoholic fatty liver disease76,77.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [77]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citation
Research works printed but not linked: 2
- A. L. Buchman, M. D. Dubin, A. A. Moukarzel, D. J. Jenden, M. Roch, K. M. Rice, J. Gornbein, M. E. Ament Hepatology 22, 1399–1403 (1995).
- S. H. Zeisel, J. S. Wishnok, J. K. Blusztajn J. Pharmacol. Exp. Ther. 225, 320–324 (1983).
Cited by
Items 601–700 of 942
Wei, Y., Liang, M., Mai, K., Zheng, K., & Xu, H. (2016) · Aquaculture Research · doi:10.1111/are.13178 · Cited by 27
Li, D., Kirsop, J., & Tang, W. H. W. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0634-1 · Cited by 29
Zhou, C., Li, G., Li, Y., Gong, L., Huang, Y., Shi, Z., Du, S., Li, Y., Wang, M., Yin, J., et al. (2014) · Molecular BioSystems · doi:10.1039/c4mb00421c · Cited by 31
Gut microbiota in health and disease
Icaza-Chávez, M. E. (2013) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2014.02.009 · Cited by 89
The role of gut microbiota in the pathogenesis of obesity and diabetes
Stachowicz, N., & Kiersztan, A. (2013) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1044746 · Cited by 30
“Może także inicjować peroksydację lipidów w obrębie organizmu gospodarza [30].”
1H NMR-Based Metabonomics for Investigating Diabetes
Maher, A. D., Lindon, J. C., & Nicholson, J. K. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.54 · Cited by 31
Self-citationThe Role of Metabolic Biomarkers in Drug Toxicity Studies
Schnackenberg, L. K., & Beger, R. D. (2008) · Toxicology Mechanisms and Methods · doi:10.1080/15376510701623193 · Cited by 29
“Global metabolic profiling is an important functional genomics tool for the determination of molecular phenotype (Gavaghan et al. 2000; Bundy et al. 2002; Clayton et al. 2006; Dumas et al. 2006b).”
MethodMicrobial functionality in the human intestinal tract
Salonen, A., Palva, A., & de Vos, W. M. (2009) · Frontiers in bioscience · doi:10.2741/3436 · Cited by 26
“Concurrently with fecal analyses, metabolomics of other sample materials have confirmed and capitalized on the fact that the impact of intestinal bacterial activity is not limited to the gut, but reaches organs and tissues well beyond it (33, 42, 44, 72-74).”
BackgroundGut–Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers
Lombardi, M., Troisi, J., Motta, B. M., Torre, P., Masarone, M., & Persico, M. (2024) · Nutrients · doi:10.3390/nu16071025 · Cited by 30
“The role of the GM in this context is highlighted by the capacity of certain microbes to metabolize choline, thereby reducing its bioavailability and generating various metabolites, including trimethylamine [27,28].”
BackgroundRole of Maternal Microbiota and Nutrition in Early-Life Neurodevelopmental Disorders
Daliry, A., & Pereira, E. N. G. D. S. (2021) · Nutrients · doi:10.3390/nu13103533 · Cited by 34
“As a result, higher triglyceride content in the liver and increased fat storage in adipocytes promote the storage of calories obtained from the diet into fat [134,139].”
BackgroundYang, B. K., Yan, S., Chen, Y., Ross, R. P., Stanton, C., Zhao, J., Zhang, H., & Chen, W. (2020) · Microorganisms · doi:10.3390/microorganisms8081108 · Cited by 36
Bollenbach, M., Ortega, M. A., Orman, M., Drennan, C. L., & Balskus, E. P. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00005 · Cited by 30
Sati, J., Mohanty, B. P., Garg, M. L., & Koul, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158955 · Cited by 28
“[52] Alternatively, phosphorylation of choline by choline kinase produces phosphorylcholine.”
BackgroundGu, S., Cao, B., Sun, R., Tang, Y., Paletta, J. L., Wu, X.-L., Liu, L., Zha, W., Zhao, C., Li, Y., et al. (2014) · Molecular BioSystems · doi:10.1039/c4mb90042a · Cited by 49
Systems Responses of Rats to Mequindox Revealed by Metabolic and Transcriptomic Profiling
Zhao, X.-J. G., Hao, F., Huang, C., Rantalainen, M., Lei, H., Tang, H., & Wang, Y. (2012) · Journal of Proteome Research · doi:10.1021/pr300533a · Cited by 26
Digestion and Postprandial Metabolism in the Elderly
Milan, A. M., & Cameron‐Smith, D. (2015) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2015.09.001 · Cited by 33
“…diets influence gut microbiota consumption of choline, leading to changes in VLDL assembly and secretion and potential alterations of bile acid conjugation, inducing metabolic abnormalities such as insulin resistance and hepatic lipid storage (Dumas et al., 2006; Musso, Gambino, & Cassader, 2010).”
BackgroundAssociation of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity
Rovella, V., Rodia, G., Daniele, F. D., Cardillo, C., Campia, U., Noce, A., Candi, E., Della‐Morte, D., & Tesauro, M. (2021) · Nutrients · doi:10.3390/nu13020613 · Cited by 25
“The microbiome also seems to affect the susceptibility to insulin resistance and promotes the development of nonalcoholic fatty liver disease [193].”
BackgroundWang, F., Xu, J., Jakovlić, I., Wang, W., & Zhao, Y. (2019) · Food & Function · doi:10.1039/c9fo01853k · Cited by 34
Role of gut microbial metabolites in nonalcoholic fatty liver disease
Zhao, Z. H., Lai, J. K., Qiao, L., & Fan, J. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12709 · Cited by 30
“Metabolic profiling in an animal model of NAFLD reveals that there is a significant increase in the concentrations of urine TMA and TMAO in 129S6 mice fed with a HFD.13 Furthermore, in a hospital- and community-based Chinese adult population, the level of circulating TMAO has been found to be associated with the occur…”
BackgroundInfluentialMetabolic Interplay between Gut Bacteria and Their Host
Duca, F. A., Gérard, P., Covașă, M., & Lepage, P. (2014) · Frontiers of hormone research · doi:10.1159/000358315 · Cited by 27
Tuohy, K. M., Fava, F., & Viola, R. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113003911 · Cited by 125
Prot, J. M., & Leclerc, É. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0480-5 · Cited by 27
The Nutrigenetics and Nutrigenomics of the Dietary Requirement for Choline
Corbin, K. D., & Zeisel, S. H. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398397-8.00007-1 · Cited by 26
Human Metabolic Phenotyping and Metabolome Wide Association Studies
Holmes, E. C., & Nicholson, J. K. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_096 · Cited by 21
Self-citationThe Pan-liver Network Theory: From Traditional Chinese Medicine to Western Medicine
Zhang, Y., & Fang, X.-M. (2023) · The Chinese Journal of Physiology · doi:10.4103/cjop.cjop-d-22-00131 · Cited by 30
Effects of Gut Metabolites and Microbiota in Healthy and Marginal Livers Submitted to Surgery
Micó-Carnero, M., Rojano-Alfonso, C., Álvarez‐Mercado, A. I., Gracia‐Sancho, J., Casillas-Ramírez, A., & Peralta, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010044 · Cited by 26
“Currently, many findings have shown alterations to GM in pathological conditions such as cardiovascular disease [18,19], cirrhosis [20], insulin resistance [21,22] or inflammatory bowel disease [23].”
BackgroundSmith, L., Klément, W., Dopavogui, L., de Bock, F., Lasserre, F., Barretto, S. A., Lukowicz, C., Fougerat, A., Polizzi, A., Schaal, B., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.106010 · Cited by 29
Zhang, Q., Tian, F., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.12.013 · Cited by 29
The Metabolic Response to Ozone
Shore, S. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02890 · Cited by 33
Host–Microbiota Mutualism in Metabolic Diseases
Fabbiano, S., Suárez-Zamorano, N., & Trajkovski, M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00267 · Cited by 26
“org October 2017 | Volume 8 | Article 267 metabolic alterations in both humans and rodent models such as obesity (6), type 2 diabetes (8), non-alcoholic fatty liver disease (NAFLD) spectrum (9), and dyslipidemia (10).”
BackgroundMadrid-Gambín, F., Llorach, R., Vázquez‐Fresno, R., Urpí-Sardà, M., Almanza‐Aguilera, E., Garcia‐Aloy, M., Estruch, R., Corella, D., & Andrés‐Lacueva, C. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00860 · Cited by 22
New insight into the gut microbiome through metagenomics
Nielsen, J., & Ji, B. (2015) · Advances in Genomics and Genetics · doi:10.2147/agg.s57215 · Cited by 41
“2 With the emergence of next-generation sequencing (NGS) technology, the role of the gut microbiome in human health and diseases is becoming clearer, and the dysbiosis of gut microbiota can be associated with numerous diseases (type 2 diabetes [T2D], inflammatory bowel disease [IBD], nonalcoholic fatty liver disease […”
InfluentialLi, H., An, Y., Zhang, L., Lei, H., Zhang, L., Wang, Y., & Tang, H. (2013) · Journal of Proteome Research · doi:10.1021/pr400440d · Cited by 41
A decade of advances in metabonomics
Barton, R. H. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.547473 · Cited by 23
“The delivery of individually personalised healthcare will require this knowledge [9], as will the treatment of many illnesses, as even short of dysbiosis, many studies have already shown the significant role of microbial metabolism in the aetiology of various diseases, for example [10].”
BackgroundSelf-citationMetabolism response of grazing yak to dietary concentrate supplementation in warm season.
Xue, B., Zhang, J., Wang, Z.-S., Wang, L.-Z., Peng, Q.-H., Da, L., Bao, S.-K., Kong, X.-Y., & Xue, B. (2021) · Animal · doi:10.1016/j.animal.2021.100175 · Cited by 22
Zhang, X., Wu, Q., Zhao, Y., Aimy, A., & Yang, X. (2019) · RSC Advances · doi:10.1039/c9ra02473e · Cited by 28
Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives
Cătoi, A. F., Vodnar, D. C., Corina, A., Nikolić, D., Citarrella, R., Pérez‐Martínez, P., & Rizzo, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190708190437 · Cited by 27
Vitlić, A., Sadiq, S., Ahmed, H. I., Ale, E. C., Binetti, A. G., Collett, A., Humpreys, P. N., & Laws, A. P. (2019) · Carbohydrate Research · doi:10.1016/j.carres.2019.03.003 · Cited by 28
Comparison of subacute effects of two types of pyrethroid insecticides using metabolomics methods
Miao, J., Wang, D., Yan, J., Wang, Y., Teng, M., Zhou, Z., & Zhu, W. (2017) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2017.08.002 · Cited by 19
Production of Fermented Kale Juices with Lactobacillus Strains and Nutritional Composition.
Kim, S. Y. (2017) · PubMed Central · doi:10.3746/pnf.2017.22.3.231 · Cited by 28
“Enriched-prebiotic products are becoming more popular in the belief that they may also have probiotic effects (23,24).”
BackgroundYan, S., Zhao, G., Liu, X., Zhao, J., Zhang, H., & Chen, W. (2017) · RSC Advances · doi:10.1039/c7ra03925e · Cited by 27
Tao, W. A. N. G., Sun, H., Hua, Y., Li, P., & Wei, Y. (2016) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(16)30018-8 · Cited by 24
Metabonomics in Diabetes Research
Faber, J. H., Malmodin, D., Toft, H., Maher, A. D., Crockford, D. J., Holmes, E. C., Nicholson, J. K., Dumas, M., & Baunsgaard, D. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100413 · Cited by 24
Self-citationTsomidis, I., Tsakou, A., Voumvouraki, A., & Kouroumalis, E. (2026) · Biomedicines · doi:10.3390/biomedicines14010151 · Cited by 25
Perazza, F., Leoni, L., Selvatici, B., Girolami, F., Bonalumi, A., Beretta, A., Ferri, S., Petroni, M. L., Piscaglia, F., Ravaioli, F., et al. (2025) · Nutrients · doi:10.3390/nu17111906 · Cited by 26
“These alterations may worsen hepatic fat accumulation, oxidative and inflammatory damage, and disrupt glucose metabolism [78,79].”
The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status
Stojić, J., Kukla, M., & Grgurević, I. (2023) · Diagnostics · doi:10.3390/diagnostics13182960 · Cited by 25
Microbiome-liver crosstalk: A multihit therapeutic target for liver disease
Kirundi, J., Moghadamrad, S., & Urbaniak, C. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i11.1651 · Cited by 26
“In a Chinese cohort study, the severity of NAFLD was closely associated with circulatory TMAO[81].”
Trimethylamine N-oxide: role in cell senescence and age-related diseases
Zhang, L., Yu, F., & Xia, J. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-03011-w · Cited by 26
Zhou, L., Li, X., Li, S., Wen, X., Peng, Y., & Zhao, L. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13143 · Cited by 31
González-Ramos, S., Paz-García, M., Fernández-García, V., Portune, K. J., Acosta-Medina, E. F., Sanz, Y., Castrillo, A., Martín‐Sanz, P., Obregón, M.-J., & Boscá, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-69295-2 · Cited by 24
Leong, K. S. W., Jayasinghe, T. N., Derraik, J. G. B., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., Jiang, Y., Schierding, W. S., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026174 · Cited by 35
Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?
Dong, T. S., & Jacobs, J. P. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219836739 · Cited by 22
“Mice fed a high-fat diet have been shown to have increased levels of gut microbes that metabolize choline and produce TMA.(84) The liver converts gut-derived TMA to trimethylamine-N-oxide (TMAO) via flavin containing monooxygenase 3.”
BackgroundInfluentialIntestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis
Dornas, W., & Lagente, V. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.026 · Cited by 25
Shanahan, F. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04135.x · Cited by 19
Microbial regulation of SAA3 expression in mouse colon and adipose tissue
Reigstad, C. S., & Bäckhed, F. (2010) · Gut Microbes · doi:10.4161/gmic.1.1.10514 · Cited by 23
Domange, C., Canlet, C., Traoré, A. S., Biélicki, G., Keller, C., Paris, A., & Priymenko, N. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800159x · Cited by 17
Ząbek, A., Pasławski, R., Pasławska, U., Wojtowicz, W., Drożdż, K., Polakof, S., Podhorska‐Okołów, M., Dzięgiel, P., Młynarz, P., & Szuba, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184798 · Cited by 20
“DMA is the product of choline metabolism by gut microbiota [45], but can also be derived from other sources such as metabolisms of TMAO [46] and asymmetric dimethylarginine (ADMA) as a product of dimethylarginine dimethylamino hydrolase (DDAH) action [47].”
BackgroundSun, Q., Li, M., Yang, X. Y., Xu, X., Wang, J., & Zhang, J. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.04.015 · Cited by 24
Wang, D., Zhang, P., Wang, X., Wang, Y., Zhou, Z., & Zhu, W. (2016) · Environmental Science and Pollution Research · doi:10.1007/s11356-015-5940-2 · Cited by 22
Xie, B., Liu, A., Zhan, X., Ye, X., & Wei, J. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf501744d · Cited by 21
In Vitro Microbiotic Fermentation Causes an Extensive Metabolite Turnover of Rye Bran Phytochemicals
Hanhineva, K., Aura, A., Rogachev, I., Matero, S., Skov, T., Aharoni, A., Poutanen, K. S., & Mykkänen, H. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039322 · Cited by 18
“However, it has so far been mainly applied to samples of mammalian origin in various set-ups [19–22].”
High Calorie Diet and the Human Brain: Metabolic Consequences of Long-Term Consumption
Farooqui, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15254-7 · Cited by 40
The role of small intestinal bacterial overgrowth in obesity and its related diseases
Yao, Q., Yu, Z., Meng, Q., Chen, J., Liu, Y., Song, W., Ren, X., Zhou, J., & Chen, X. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115546 · Cited by 21
Deciphering the role of gut metabolites in non-alcoholic fatty liver disease
Ralli, T., Saifi, Z., Tyagi, N., Vidyadhari, A., Aeri, V., & Kohli, K. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2142091 · Cited by 23
“In various studies TMAO was shown to be involved in various diseases like, a) it increases the risk of CV diseases by promoting atherosclerosis (Rath et al. 2017), b) causes development of insulin resistance and thus development of T2DM (Dumas et al. 2006; Le (cid:1) on-Mimila et al. 2021), c) promotes inflammation in…”
BackgroundSun, Y., He, Z., Li, J., Gong, S., Yuan, S., Li, T., Ning, N., Xing, L., Zhang, L., Chen, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.608895 · Cited by 23
“Several mechanisms by which gut microorganisms can modulate the development of metabolic diseases have been reported (8, 9).”
BackgroundVariation in the gut microbial community is associated with the progression of liver regeneration
Bao, Q., Yu, L., Chen, D., & Li, L. (2019) · Hepatology Research · doi:10.1111/hepr.13424 · Cited by 24
Microbiota, Liver Diseases, and Alcohol
Cassard, A., Gérard, P., & Perlemuter, G. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0007-2016 · Cited by 23
“Indeed, the high capacity of the gut microbiota to metabolize choline into methylamines explains the high susceptibility to develop NAFLD in response to an HFD in mouse strain 129S6 (59).”
BackgroundTranchida, F., Rakotoniaina, Z., Shintu, L., Tchiakpe, L., Deyris, V., Yemloul, M., Stocker, P., Vidal, N., Rimet, O., Hiol, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06220-0 · Cited by 23
Phetcharaburanin, J., Lees, H., Marchesi, J. R., Nicholson, J. K., Holmes, E. C., Seyfried, F., & Li, J. V. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00090 · Cited by 19
Self-citationPontoizeau, C., Fearnside, J. F., Navratil, V., Domange, C., Cazier, J., Fernández-Santamaría, C., Kaisaki, P., Emsley, L., Toulhoat, P., Bihoreau, M., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr101000z · Cited by 19
Self-citationJia, W. P., & Rajani, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_8 · Cited by 29
Costa, J. S. R., Fonseca, G. F. A. C., Ottone, N. C. D. S., Silva, P. A., Antonaccio, R. F., Silva, G., Rocha, M. D. S. A., Coimbra, C. C., Esteves, E. A., Mang, Z. A., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119639 · Cited by 21
Abdelhalim, K. A., Uzel, A., & Ünal, N. G. (2020) · Gastroenterology Review · doi:10.5114/pg.2020.93235 · Cited by 21
Wang, M., Zhang, X., Wang, Y., Li, Y., Chen, Y., Zheng, H., Ma, F., Ma, C. W., Lu, B., Xie, Z., et al. (2018) · RSC Advances · doi:10.1039/c7ra12067b · Cited by 26
Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis
Qamar, A. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000347 · Cited by 18
Role of epigenetic reprogramming of host genes in bacterial pathogenesis
Alakeel, R. A. (2013) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2013.05.003 · Cited by 26
“A role of mammalian gut microbiota, as epigenetic modifying factor, in the pathogenesis of metabolic syndrome and associated diseases has been meant (Dumas et al., 2006).”
BackgroundHazen, S. L., & Smith, J. D. (2012) · Circulation Research · doi:10.1161/circresaha.112.277277 · Cited by 23
Influence of the Human Gut Microbiome on the Metabolic Phenotype
Hoyles, L., & Swann, J. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812293-8.00018-9 · Cited by 28
Metabolomics: Approaches and Applications to Diabetes Research
Preet, A. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s6-001 · Cited by 16
Zhang, W., Jia, X., Xu, Y., Xie, Q., Zhu, M., Zhang, H., Zhao, Z., Hao, J., Li, H., Du, J., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.939423 · Cited by 17
“Endocrine signaling regulates triglyceride, cholesterol, glucose and energy homeostasis (14, 15).”
BackgroundFeng, W., Liu, J., Cheng, H., & Peng, C. Y. (2021) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-021-3305-x · Cited by 19
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease
Hartmann, P., & Schnabl, B. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1719174 · Cited by 22
“Another metabolite, choline, has been implicated in the pathogenesis of NAFLD based on animal studies [11,62], however this could not be convincingly shown in human studies [63,64].”
BackgroundMetabonomic Responses of Grazing Yak to Different Concentrate Supplementations in Cold Season
Zhou, J., Yue, S., Peng, Q., Wang, L., Wang, Z., & Bai, X. (2020) · Animals · doi:10.3390/ani10091595 · Cited by 25
“Excess choline could be used for the synthesis of phosphorylcholine [43], then enhance VLDL synthesis in the liver [44].”
BackgroundNoerman, S., Kolehmainen, M., & Hanhineva, K. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa031 · Cited by 25
“Because the plasma sample was reported to better reflect individual lipid and energy metabolism due to environmental factors and risk of metabolic diseases (9), the included research articles and the discussion thereafter will focus on metabolites discovered from blood samples.”
BackgroundSite specific microbiome of Leishmania parasite and its cross-talk with immune milieu
Misra, P., & Singh, S. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.10.004 · Cited by 17
Maulidiani, M., Rudiyanto, R., Mediani, A., Khatib, A., Ismail, A., Hamid, M., Lajis, N. H., Shaari, K., & Abas, F. (2017) · Metabolomics · doi:10.1007/s11306-017-1273-0 · Cited by 18
“It was also reported that high conversion of choline to methylamines in the mice fed with HFD diets (Dumas et al. 2006).”
BackgroundSagami, S., Ueno, Y., Tanaka, S., Fujita, A., Niitsu, H., Hayashi, R., Hyogo, H., Hinoi, T., Kitadai, Y., & Chayama, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169681 · Cited by 18
Chapter 1 Biomedical Agriculture
Thompson, M. D., & Thompson, H. J. (2009) · Advances in agronomy · doi:10.1016/s0065-2113(09)01001-3 · Cited by 17
Defining Personal Nutrition and Metabolic Health Through Metabonomics
Rezzi, S., Martin, F., & Kochhar, S. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_097 · Cited by 19
Goya‐Jorge, E., Gonza, I., Bondue, P., Douny, C., Taminiau, B., Daube, G., Scippo, M., & Delcenserie, V. (2022) · Foods · doi:10.3390/foods11131946 · Cited by 18
“Methylamines are directly related to gut microbiota metabolism [118].”
BackgroundMatsumoto, M., Inoüe, R., Tsuruta, T., Hara, H., & Yajima, T. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509990365 · Cited by 20
“It has been demonstrated in experimental animals that alterations in intestinal microbiota have a marked impact on insulin resistance((25,26)).”
BackgroundNMR-Based Metabolomics for Biomarker Discovery
Shanaiah, N., Zhang, S., DeSilva, M. A., & Raftery, D. (2008) · Methods in pharmacology and toxicology · doi:10.1007/978-1-59745-463-6_16 · Cited by 14
The human microbiota key role in the bone metabolism activity.
Inchingolo, A. M., Isacco, C. G., Inchingolo, A. D., Nguyen, K. C. D., Cantore, S., Santacroce, L., Scacco, S., Cirulli, N., Corriero, A., Puntillo, F., et al. (2023) · PubMed · doi:10.26355/eurrev_202303_31803 · Cited by 18
“The local genera tend to be stable in number and diversity and any increased level of microbial variety is linked to the insurgence of chronic inflammation responses and different types of dysplasia (Figure 1) 5,53-59 .”
BackgroundJi, L., Deng, H., Xue, H., Wang, J., Hong, K., Gao, Y., Kang, X., Fan, G., Huang, W., Zhan, J., et al. (2023) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13106 · Cited by 16
de la Rocha, C., Rodríguez‐Ríos, D., Ramírez-Chávez, E., Molina‐Torres, J., Flores-Sierra, J. D. J., Castellanos, L. M. O., Galván-Chía, J. P., Vázquez-Sánchez, A., Zaina, S., & Lund, G. (2022) · Cells · doi:10.3390/cells11061057 · Cited by 17
“This is a remarkable response, given that BALB/c mice are relatively resistant to treatments aimed at increasing body weight, such as obesogenic diets [51,52].”
BackgroundHe, X., Jiang, J., & Zhang, X. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-19369-7 · Cited by 19
“Studies have shown that TMAO has hepatotoxicity and can damage the homeostasis of glucose and lipid metabolism (Dumas et al. 2006).”
BackgroundThe microbial metabolome in metabolic‐associated fatty liver disease
Li, M., Rajani, C., Zheng, X., & Jia, W. P. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15746 · Cited by 17
DNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease
Tommasi, S., & Nia, A. B. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16152791 · Cited by 16
“As a consequence, tissues exposed to high concentrations of these bacterial metabolites, such as the intestinal epithelium or the liver, may undergo epigenetic changes affecting genes involved in metabolic regulation and, in the long run, alter organ homeostasis and predispose the host to metabolic chronic disease, in…”
BackgroundMetabolomics Insights into the Modulatory Effects of Long-Term Low Calorie Intake in Mice
Wu, J., Liu, Y., Li, S., Huang, P., Liu, Y., Wang, Y., & Tang, H. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00336 · Cited by 18
Gandhi, S., Devi, M. M., Pal, S., Tripathi, R. P., & Khushu, S. (2011) · Metabolomics · doi:10.1007/s11306-011-0326-z · Cited by 13
“Stress is a combination of events beginning with a stimulus, which precipitates a reaction in the brain and subsequently results in the activation of certain physiologic systems in the body i.e., stress response ( Dhabhar et al. 1997 ).”
Background
Metadata
- Authors
- Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., & Nicholson, J. K.
- Affiliations
- Imperial College London (GB)
- *Department of Biological Chemistry and
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-15
- Volume
- 103
- Issue
- 33
- Pages
- 12511-12516
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1567909
- OpenAlex
- W2139464173
- Cited by
- 1,042
- References
- 0
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 29 · 2023: 26 · 2022: 43 · 2021: 57 · 2020: 52 · 2019: 80 · 2018: 70 · 2017: 67 · 2016: 86 · 2015: 72 · 2014: 63 · 2013: 80 · 2012: 62
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (057733, 066786)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- gut microbiota, non-alcoholic fatty liver disease, insulin resistance, choline metabolism, phosphatidylcholine, trimethylamine N-oxide, methylamine, high-fat diet, impaired glucose homeostasis, metabotyping, host-microbe interactions, choline deficiency
- MeSH terms
- Animals, Body Weight, Dietary Fats, Fatty Liver, Glucose, Homeostasis, Insulin, Insulin Resistance, Lipids, Liver, Male, Methylamines, Mice, Inbred BALB C, Phenotype, Multivariate Analysis, Nuclear Magnetic Resonance, Biomolecular, Gastrointestinal Tract, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.